Liu Huan, Nail Aminov, Meng Decheng, Zhu Liran, Guo Xiaohan, Li Cong, Li Huan-Jun
Key Laboratory of Cluster Science of Ministry of Education, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering of Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, 100081 Beijing, China.
Key Laboratory of Cluster Science of Ministry of Education, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering of Ministry of Industry and Information Technology, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, 100081 Beijing, China.
Int J Pharm. 2025 Jan 5;668:124995. doi: 10.1016/j.ijpharm.2024.124995. Epub 2024 Nov 23.
3D-printed microneedles (MNs) have emerged as a transformative technology in drug delivery, diagnostics, and cosmetics, providing a minimally invasive alternative to traditional methods. This review highlights the advancements in 3D printing technologies, including fused deposition modeling (FDM), digital light processing (DLP), and stereolithography (SLA), which enable the precise fabrication of MNs with customizable geometries and functionalities. The unique ability of MNs to penetrate the stratum corneum facilitates enhanced delivery of therapeutic agents, biosensing capabilities, and improved patient compliance. Recent innovations in MNs design, such as biomimetic structures and optimized geometries, have significantly improved their mechanical properties and drug delivery efficiency. Furthermore, integrating sensing elements within MNs enables real-time monitoring of biomarkers, paving the way for personalized medicine. Despite the promising applications, challenges remain, including regulatory considerations, material biocompatibility, and manufacturing scalability. This review discusses the current state of 3D-printed MNs, their diverse applications, and future directions. By addressing existing limitations and exploring novel materials and hybrid fabrication techniques, 3D-printed MNs have the potential to revolutionize healthcare delivery and improve patient outcomes.
3D打印微针已成为药物递送、诊断和化妆品领域的一项变革性技术,为传统方法提供了一种微创替代方案。本综述重点介绍了3D打印技术的进展,包括熔融沉积建模(FDM)、数字光处理(DLP)和立体光刻(SLA),这些技术能够精确制造具有可定制几何形状和功能的微针。微针穿透角质层的独特能力有助于增强治疗剂的递送、生物传感能力并提高患者的依从性。微针设计的最新创新,如仿生结构和优化的几何形状,显著改善了它们的机械性能和药物递送效率。此外,在微针中集成传感元件能够实时监测生物标志物,为个性化医疗铺平了道路。尽管应用前景广阔,但挑战依然存在,包括监管考量、材料生物相容性和制造可扩展性。本综述讨论了3D打印微针的现状、其多样的应用以及未来方向。通过解决现有局限性并探索新型材料和混合制造技术,3D打印微针有潜力彻底改变医疗保健服务并改善患者预后。